ArticleJournal of cellular and molecular medicine2021

Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel-sensitive and docetaxel-resistant castration-resistant prostate cancer cells.

Senmao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.